Risk factors for middle east respiratory syndrome Coronavirus infection among healthcare personnel

Emerging Infectious Diseases

Volumn 22, Issue 11, 2016, Pages 1915-1920

  Alraddadi, Basem M ^a,b   Al Salmi, Hanadi S ^a   Jacobs Slifka, Kara ^c   Slayton, Rachel B ^c   Estivariz, Concepcion F ^c   Geller, Andrew I ^c   Al Turkistani, Hanan H ^a   Al Rehily, Sanaa S ^a   Alserehi, Haleema A ^a   Wali, Ghassan Y ^a   Alshukairi, Abeer N ^a   Azhar, Esam I ^b,d   Haynes, Lia ^c   Swerdlow, David L ^c   Jernigan, John A ^c   Madani, Tariq A ^b,d  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; CORONAVIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR; SAUDI ARABIA; SEROEPIDEMIOLOGY; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CORONAVIRUS INFECTIONS; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84992161353     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2211.160920     Document Type: Article

References (25)

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2016 May 1]. http://www.who.int/emergencies/mers-cov/en/
2. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): summary of current situation, literature update and risk assessment—as of 5 February 2015 [cited 2015 Feb 5]. http://www.who.int/csr/disease/coronavirus_infections/mers-5-february-2015.pdf?ua=1
3. World Health Organization. MERS-CoV in Republic of Korea at a glance as of 29 July 2015 [cited 2015 Jul 29]. http://www.wpro.who.int/outbreaks_emergencies/wpro_coronavirus/en/
4. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014;370:2499-505. http://dx.doi.org/10.1056/NEJMoa1401505
5. Kayali G, Peiris M. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2015;15:495-7. http://dx.doi.org/10.1016/S1473-3099(15)70128-3
6. Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr. 2014;6:6.
7. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15:629. http://dx.doi.org/10.1016/S1473-3099(15)70090-3
8. Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, et al. An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369-77. http://dx.doi.org/10.1093/cid/ciu812
9. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med. 2015;372:846-54. http://dx.doi.org/10.1056/NEJMoa1408636
10. Scientific Advisory Council of the Saudi Arabia Ministry of Health. Infection prevention/control and management guidelines for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection [cited 2014 Dec 8]. http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf
11. World Health Organization. Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infection [cited 2013 May 6]. http://www.who.int/csr/ disease/coronavirus_infections/IPCnCoVguidance:06May13.pdf?ua=1
12. World Health Organization. WHO statement on the eighth meeting of the IHR Emergency Committee regarding MERS-CoV [cited 2015 Feb 5]. http://www.who.int/mediacentre/news/statements/2015/8th-mers-emergency-committee/en/
13. Perl TM, Price CS. Orchestrated scientific collaboration: critical to the control of MERS-CoV. Ann Intern Med. 2015;163:313-4. http://dx.doi.org/10.7326/M15-1395
14. Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, et al.; Jordan MERS-CoV Investigation Team. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014;59:1225-33. http://dx.doi.org/10.1093/cid/ciu359
15. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al.; KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-16. http://dx.doi.org/10.1056/NEJMoa1306742
16. Health Protection Agency UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill. 2013;18:20427.
17. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Al-Rabeeah AA, Assiri A, Alhakeem RF, et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect. 2014;20:469-74. http://dx.doi.org/10.1111/1469-0691.12562
18. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis. 2013;207:1037-46. http://dx.doi.org/10.1093/infdis/jis773
19. Hall CB. InfluenzaVirus: here, there, especially air? J Infect Dis. 2013;207:1027-9. http://dx.doi.org/10.1093/infdis/jis774
20. Loeb M, McGeer A, Henry B, Ofner M, Rose D, Hlywka T, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis. 2004;10:251-5. http://dx.doi.org/10.3201/eid1002.030838
21. Roy CJ, Milton DK. Airborne transmission of communicable infection—the elusive pathway. N Engl J Med. 2004;350:1710-2. http://dx.doi.org/10.1056/NEJMp048051
22. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface. 2009;6(Suppl 6):S783-90. http://dx.doi.org/10.1098/rsif.2009.0302.focus
23. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-61. http://dx.doi.org/10.1016/ S1473-3099(13)70204-4
24. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013;368:2487-94. http://dx.doi.org/10.1056/NEJMoa1303729
25. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15:559-64. http://dx.doi.org/10.1016/S1473-3099(15)70090-3